European equities traded in the US as American depositary receipts were moving lower late Wednesday morning, declining 0.27% to 1,442.84 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical companies argenx (ARGX) and Genfit (GNFT), which rose 4.3% and 3.6% respectively. They were followed by pharmaceutical company Ascendis Pharma (ASND) and internet advertising company Criteo (CRTO), which increased 2.9% and 2% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which fell 6.3% and 3.2% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and software vendor SAP (SAP), which dropped 3% and 2.4% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Amarin (AMRN), which advanced 11% and 2% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and mining company BHP Group (BHP), which were up 1.4% and 0.7% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and Trinity Biotech (TRIB) 5.7% and 4% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and oil major BP (BP), which fell 2.8% and 2.5% respectively.
Comments